National Bank of Canada delivered its quarterly results on August 26 into what has been a bruising week for the Canadian banking sector — the stock itself slipped 1.6% on the week even as it bounced 2.5% on the day of the print, a pattern worth keeping in mind as the dust settles.
The peer group adds context here. Most of the major Canadian lenders also lost ground over the past five trading days: CIBC fell 3.2%, TD dropped 2.9%, and Royal Bank shed 3.3%. BMO was the notable laggard, down 5.5%. The lone outlier was BNS, which gained 2.7% on the week — suggesting some idiosyncratic rotation within the sector rather than a clean macro bid or sell. National Bank's own 1.6% weekly decline was therefore relatively contained against this backdrop.
The borrow market carries essentially no short thesis at present. Availability is at its maximum ceiling — effectively the entire lending pool remains untouched — with utilization running below 1%. Borrowing costs are unremarkable at roughly 0.72%, down around 9% from a month ago, and have shown no sustained trend toward higher levels. Short interest registers a low ORTEX short score of 29.6, placing it in the less-pressured portion of the universe. There is no meaningful borrow squeeze risk visible in the lending data.
The Street's read is closely aligned with the current price. The analyst consensus price target sits at CAD 223.29, almost exactly where the stock closed on August 25 at CAD 222.53 — implying virtually no upside is priced into sell-side models right now. No recent analyst changes are recorded in the data. On valuation, the stock trades at a trailing P/E of roughly 16.9x and a price-to-book of 2.69x. The book value multiple has drifted down about 4.4% over the past thirty days, a quiet re-rating lower that has tracked the stock's modest 2.1% monthly decline. The dividend factor score ranks in the 76th percentile, reflecting National Bank's consistent income profile — though it should be noted that the dividend history data in the snapshot is stale and runs only to mid-2022, so the absolute yield figure should be treated with caution.
One directional signal worth noting is insider activity. Director Yvon Charest made a small open-market purchase of 191 shares on August 18 at CAD 233.21, shortly before the earnings release. That follows an identical pattern from May 19, when the same director bought 228 shares at CAD 203.94 ahead of the prior quarter's results. The individual amounts are modest in dollar terms — well under CAD 50,000 each time — but the consistency of the timing is a notable behavioral signal from someone with board-level visibility.
The next scheduled earnings event is December 2. Between now and then, the key variable is how the Canadian macroeconomic picture evolves — National Bank's Quebec-concentrated franchise makes it particularly sensitive to domestic credit conditions and rate dynamics. The question coming out of today's print is whether the stock's relative resilience versus peers holds, or whether the sector-wide pressure reasserts itself into year-end.
See the live data behind this article on ORTEX.
Open NA on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
